List of Tables
Table 1. Global Viable Tumor Samples Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Viable Tumor Samples Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Viable Tumor Samples Market Competitive Situation by Manufacturers in 2024
Table 4. Global Viable Tumor Samples Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Viable Tumor Samples Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Viable Tumor Samples Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Viable Tumor Samples Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Viable Tumor Samples Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Viable Tumor Samples, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Viable Tumor Samples, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Viable Tumor Samples, Product Type & Application
Table 12. Global Key Manufacturers of Viable Tumor Samples, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Viable Tumor Samples by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viable Tumor Samples as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Viable Tumor Samples Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Viable Tumor Samples Sales by Region (2020-2025) & (K Units)
Table 18. Global Viable Tumor Samples Sales Market Share by Region (2020-2025)
Table 19. Global Viable Tumor Samples Sales by Region (2026-2031) & (K Units)
Table 20. Global Viable Tumor Samples Sales Market Share by Region (2026-2031)
Table 21. Global Viable Tumor Samples Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Viable Tumor Samples Revenue Market Share by Region (2020-2025)
Table 23. Global Viable Tumor Samples Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Viable Tumor Samples Revenue Market Share by Region (2026-2031)
Table 25. North America Viable Tumor Samples Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Viable Tumor Samples Sales by Country (2020-2025) & (K Units)
Table 27. North America Viable Tumor Samples Sales by Country (2026-2031) & (K Units)
Table 28. North America Viable Tumor Samples Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Viable Tumor Samples Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Viable Tumor Samples Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Viable Tumor Samples Sales by Country (2020-2025) & (K Units)
Table 32. Europe Viable Tumor Samples Sales by Country (2026-2031) & (K Units)
Table 33. Europe Viable Tumor Samples Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Viable Tumor Samples Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Viable Tumor Samples Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Viable Tumor Samples Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Viable Tumor Samples Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Viable Tumor Samples Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Viable Tumor Samples Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Viable Tumor Samples Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Viable Tumor Samples Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Viable Tumor Samples Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Viable Tumor Samples Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Viable Tumor Samples Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Viable Tumor Samples Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Viable Tumor Samples Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Viable Tumor Samples Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Viable Tumor Samples Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Viable Tumor Samples Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Viable Tumor Samples Sales (K Units) by Type (2020-2025)
Table 51. Global Viable Tumor Samples Sales (K Units) by Type (2026-2031)
Table 52. Global Viable Tumor Samples Sales Market Share by Type (2020-2025)
Table 53. Global Viable Tumor Samples Sales Market Share by Type (2026-2031)
Table 54. Global Viable Tumor Samples Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Viable Tumor Samples Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Viable Tumor Samples Revenue Market Share by Type (2020-2025)
Table 57. Global Viable Tumor Samples Revenue Market Share by Type (2026-2031)
Table 58. Global Viable Tumor Samples Price (US$/Unit) by Type (2020-2025)
Table 59. Global Viable Tumor Samples Price (US$/Unit) by Type (2026-2031)
Table 60. Global Viable Tumor Samples Sales (K Units) by Application (2020-2025)
Table 61. Global Viable Tumor Samples Sales (K Units) by Application (2026-2031)
Table 62. Global Viable Tumor Samples Sales Market Share by Application (2020-2025)
Table 63. Global Viable Tumor Samples Sales Market Share by Application (2026-2031)
Table 64. Global Viable Tumor Samples Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Viable Tumor Samples Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Viable Tumor Samples Revenue Market Share by Application (2020-2025)
Table 67. Global Viable Tumor Samples Revenue Market Share by Application (2026-2031)
Table 68. Global Viable Tumor Samples Price (US$/Unit) by Application (2020-2025)
Table 69. Global Viable Tumor Samples Price (US$/Unit) by Application (2026-2031)
Table 70. StoreMyTumor Company Information
Table 71. StoreMyTumor Description and Business Overview
Table 72. StoreMyTumor Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. StoreMyTumor Viable Tumor Samples Product
Table 74. StoreMyTumor Recent Developments/Updates
Table 75. Cureline, Inc. Company Information
Table 76. Cureline, Inc. Description and Business Overview
Table 77. Cureline, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Cureline, Inc. Viable Tumor Samples Product
Table 79. Cureline, Inc. Recent Developments/Updates
Table 80. Conversant Bio Company Information
Table 81. Conversant Bio Description and Business Overview
Table 82. Conversant Bio Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Conversant Bio Viable Tumor Samples Product
Table 84. Conversant Bio Recent Developments/Updates
Table 85. Fluxion Biosciences Company Information
Table 86. Fluxion Biosciences Description and Business Overview
Table 87. Fluxion Biosciences Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Fluxion Biosciences Viable Tumor Samples Product
Table 89. Fluxion Biosciences Recent Developments/Updates
Table 90. Miltenyi Biotech Company Information
Table 91. Miltenyi Biotech Description and Business Overview
Table 92. Miltenyi Biotech Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Miltenyi Biotech Viable Tumor Samples Product
Table 94. Miltenyi Biotech Recent Developments/Updates
Table 95. Crown Bioscience, Inc. Company Information
Table 96. Crown Bioscience, Inc. Description and Business Overview
Table 97. Crown Bioscience, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Crown Bioscience, Inc. Viable Tumor Samples Product
Table 99. Crown Bioscience, Inc. Recent Developments/Updates
Table 100. Indivumed GmbH Company Information
Table 101. Indivumed GmbH Description and Business Overview
Table 102. Indivumed GmbH Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Indivumed GmbH Viable Tumor Samples Product
Table 104. Indivumed GmbH Recent Developments/Updates
Table 105. Illumina, Inc. Company Information
Table 106. Illumina, Inc. Description and Business Overview
Table 107. Illumina, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Illumina, Inc. Viable Tumor Samples Product
Table 109. Illumina, Inc. Recent Developments/Updates
Table 110. QIAGEN NV Company Information
Table 111. QIAGEN NV Description and Business Overview
Table 112. QIAGEN NV Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. QIAGEN NV Viable Tumor Samples Product
Table 114. QIAGEN NV Recent Developments/Updates
Table 115. Neogenomics Laboratories, Inc. Company Information
Table 116. Neogenomics Laboratories, Inc. Description and Business Overview
Table 117. Neogenomics Laboratories, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Neogenomics Laboratories, Inc. Viable Tumor Samples Product
Table 119. Neogenomics Laboratories, Inc. Recent Developments/Updates
Table 120. HTG Molecular Diagnostics Company Information
Table 121. HTG Molecular Diagnostics Description and Business Overview
Table 122. HTG Molecular Diagnostics Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. HTG Molecular Diagnostics Viable Tumor Samples Product
Table 124. HTG Molecular Diagnostics Recent Developments/Updates
Table 125. Genomic Health, Inc. Company Information
Table 126. Genomic Health, Inc. Description and Business Overview
Table 127. Genomic Health, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Genomic Health, Inc. Viable Tumor Samples Product
Table 129. Genomic Health, Inc. Recent Developments/Updates
Table 130. Thermo Fischer Company Information
Table 131. Thermo Fischer Description and Business Overview
Table 132. Thermo Fischer Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Thermo Fischer Viable Tumor Samples Product
Table 134. Thermo Fischer Recent Developments/Updates
Table 135. BGI Genomics Co., Ltd. Company Information
Table 136. BGI Genomics Co., Ltd. Description and Business Overview
Table 137. BGI Genomics Co., Ltd. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. BGI Genomics Co., Ltd. Viable Tumor Samples Product
Table 139. BGI Genomics Co., Ltd. Recent Developments/Updates
Table 140. Bruker Biosciences Corp. Company Information
Table 141. Bruker Biosciences Corp. Description and Business Overview
Table 142. Bruker Biosciences Corp. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Bruker Biosciences Corp. Viable Tumor Samples Product
Table 144. Bruker Biosciences Corp. Recent Developments/Updates
Table 145. Cepheid, Inc. Company Information
Table 146. Cepheid, Inc. Description and Business Overview
Table 147. Cepheid, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Cepheid, Inc. Viable Tumor Samples Product
Table 149. Cepheid, Inc. Recent Developments/Updates
Table 150. Promega Corporation Company Information
Table 151. Promega Corporation Description and Business Overview
Table 152. Promega Corporation Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Promega Corporation Viable Tumor Samples Product
Table 154. Promega Corporation Recent Developments/Updates
Table 155. Applied Biosystems, Inc. Company Information
Table 156. Applied Biosystems, Inc. Description and Business Overview
Table 157. Applied Biosystems, Inc. Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Applied Biosystems, Inc. Viable Tumor Samples Product
Table 159. Applied Biosystems, Inc. Recent Developments/Updates
Table 160. Natera Company Information
Table 161. Natera Description and Business Overview
Table 162. Natera Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Natera Viable Tumor Samples Product
Table 164. Natera Recent Developments/Updates
Table 165. Agilent Company Information
Table 166. Agilent Description and Business Overview
Table 167. Agilent Viable Tumor Samples Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Agilent Viable Tumor Samples Product
Table 169. Agilent Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Viable Tumor Samples Distributors List
Table 173. Viable Tumor Samples Customers List
Table 174. Viable Tumor Samples Market Trends
Table 175. Viable Tumor Samples Market Drivers
Table 176. Viable Tumor Samples Market Challenges
Table 177. Viable Tumor Samples Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Viable Tumor Samples
Figure 2. Global Viable Tumor Samples Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viable Tumor Samples Market Share by Type: 2024 & 2031
Figure 4. Flash Frozen Tumor Samples Product Picture
Figure 5. Fresh Tumor Samples Product Picture
Figure 6. Global Viable Tumor Samples Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Viable Tumor Samples Market Share by Application: 2024 & 2031
Figure 8. Lung Cancer
Figure 9. Prostate Cancer
Figure 10. Breast Cancer
Figure 11. Lymphoma
Figure 12. Leukemia
Figure 13. Others
Figure 14. Global Viable Tumor Samples Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Viable Tumor Samples Market Size (2020-2031) & (US$ Million)
Figure 16. Global Viable Tumor Samples Sales (2020-2031) & (K Units)
Figure 17. Global Viable Tumor Samples Average Price (US$/Unit) & (2020-2031)
Figure 18. Viable Tumor Samples Report Years Considered
Figure 19. Viable Tumor Samples Sales Share by Manufacturers in 2024
Figure 20. Global Viable Tumor Samples Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Viable Tumor Samples Players: Market Share by Revenue in Viable Tumor Samples in 2024
Figure 22. Viable Tumor Samples Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Viable Tumor Samples Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Viable Tumor Samples Sales Market Share by Country (2020-2031)
Figure 25. North America Viable Tumor Samples Revenue Market Share by Country (2020-2031)
Figure 26. United States Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Viable Tumor Samples Sales Market Share by Country (2020-2031)
Figure 29. Europe Viable Tumor Samples Revenue Market Share by Country (2020-2031)
Figure 30. Germany Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Viable Tumor Samples Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Viable Tumor Samples Revenue Market Share by Region (2020-2031)
Figure 37. China Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Viable Tumor Samples Sales Market Share by Country (2020-2031)
Figure 45. Latin America Viable Tumor Samples Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Viable Tumor Samples Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Viable Tumor Samples Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Viable Tumor Samples Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Viable Tumor Samples by Type (2020-2031)
Figure 55. Global Revenue Market Share of Viable Tumor Samples by Type (2020-2031)
Figure 56. Global Viable Tumor Samples Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Viable Tumor Samples by Application (2020-2031)
Figure 58. Global Revenue Market Share of Viable Tumor Samples by Application (2020-2031)
Figure 59. Global Viable Tumor Samples Price (US$/Unit) by Application (2020-2031)
Figure 60. Viable Tumor Samples Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
